Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-03-28

Clinical Trial Update: Cost-effectiveness of TPMT Pharmacogenetics [NA]

View source ↗

Summary

A completed study evaluating the cost-effectiveness of TPMT pharmacogenetic testing in inflammatory bowel diseases, including Crohn's disease and ulcerative col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ZonMw: The Netherlands Organisation for Health Research and Development | Conditions: Inflammatory Bowel Diseases, Crohn Disease | NA | Status: COMPLETED